A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis

Clinical trial NCT07185282 · COMPLETED

Trial details

NCT number: NCT07185282
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2023-06-10
Primary completion: 2024-12-13
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.